$2.75 -0.07 (%) Immunogen Inc - NASDAQ

Sep. 26, 2016 | 01:25 PM

Partner Headlines

  1. ImmunoGen Announces Recent Product Program Advancements and Anticipated 2016 Events in Advance of J.P. Morgan Healthcare Conference

    Benzinga | Jan. 10, 2016 | 18:13PM EST
  2. Mid-Morning Market Update: Markets Edge Higher; Deere Profit Tops Views

    Benzinga | Nov. 25, 2015 | 10:16AM EST
  3. Response to ImmunoGen's Mirvetuximab Soravtansine Found to be Substantially Greater in Ovarian Cancer with High Expression of Folate Receptor Alpha

    Benzinga | Nov. 8, 2015 | 16:56PM EST
  4. Benzinga's Top Downgrades

    Benzinga | Sep. 22, 2015 | 09:45AM EST
  5. Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

    Benzinga | Sep. 21, 2015 | 10:29AM EST
  6. Morning Market Losers

    Benzinga | Sep. 21, 2015 | 09:52AM EST
  7. Benzinga's Top Downgrades

    Benzinga | Sep. 21, 2015 | 09:41AM EST
  8. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 21, 2015 | 08:21AM EST
  9. Stocks Easing Off Day's Lows; Caesarstone Rebounds

    IBD | Aug. 7, 2015 | 13:00PM EST
  10. Stocks Start Little Changed; CDW Jumps On Earnings

    IBD | Aug. 3, 2015 | 10:28AM EST
  11. Benzinga's Top Downgrades

    Benzinga | Aug. 3, 2015 | 09:25AM EST
  12. Stocks Stay Near Session Highs; ImmunoGen Surges

    IBD | Jul. 16, 2015 | 14:52PM EST
  13. Stocks Hold Near Day's High; Amazon, Immunogen Break Out

    IBD | Jul. 13, 2015 | 13:25PM EST
  14. ASCO Moves Pharma Shares

    IBD | Jun. 1, 2015 | 18:52PM EST
  15. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  16. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  17. ImmunoGen Shares Looking Healthy After Favorable IMGN853 Report

    Benzinga | Jun. 1, 2015 | 11:52AM EST
  18. Benzinga's Volume Movers

    Benzinga | Jun. 1, 2015 | 10:58AM EST
  19. Morning Market Gainers

    Benzinga | Jun. 1, 2015 | 10:16AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 1, 2015 | 08:08AM EST
  21. Here's Why Oppenheimer Upgraded ImmunoGen To Outperform

    Benzinga | Feb. 6, 2015 | 10:45AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 2, 2015 | 08:23AM EST
  23. Gulf Resources (GURE) Soars on Natural Gas Discovery, ImmunoGen (IMGN) and Synaptics (SYNA) ...

    GuruFocus | Jan. 31, 2015 | 20:55PM EST
  24. ImmunoGen Shares Surge 30% Following Earnings

    Benzinga | Jan. 30, 2015 | 14:16PM EST
  25. Earnings Scheduled For January 30, 2015

    Benzinga | Jan. 30, 2015 | 04:57AM EST
  26. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  27. Roche Halts Alzheimer's Trial

    IBD | Dec. 19, 2014 | 18:47PM EST
  28. Mid-Day Losers From December 19: ImmunoGen, NQ Mobile And More

    Benzinga | Dec. 19, 2014 | 13:33PM EST
  29. Juno Therapeutics IPO Caps Big Year In Biotech Deals

    IBD | Dec. 19, 2014 | 12:47PM EST
  30. Top 3 Short Ideas Among Friday's Losers

    Benzinga | Dec. 19, 2014 | 12:21PM EST
  31. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD | Dec. 19, 2014 | 11:31AM EST
  32. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 19, 2014 | 09:33AM EST
  33. #PreMarket Movers From December 19, 2014: NQ Mobile, BlackBerry, CarMax And More

    Benzinga | Dec. 19, 2014 | 09:20AM EST
  34. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus | Jul. 30, 2014 | 19:21PM EST
  35. Wednesday's Biggest Movers

    Benzinga | Jun. 25, 2014 | 16:49PM EST
  36. Shares Of ImmunoGen Down On Morgan Stanley's Bearish Initiation

    Benzinga | Jun. 25, 2014 | 08:26AM EST
  37. Benzinga's Top Initiations

    Benzinga | Jun. 25, 2014 | 08:21AM EST
  38. UPDATE: Canaccord Genuity Initiates Coverage on ImmunoGen Ahead of Phase 3 Data

    Benzinga | Apr. 16, 2014 | 09:29AM EST
  39. ImmunoGen Says Initial Research Shows New Dosing Approach for IMGN853 Achieves Objective

    Benzinga | Apr. 8, 2014 | 16:17PM EST
  40. IDEXX Laboratories Elects Daniel Junius to Board of Directors

    Benzinga | Mar. 11, 2014 | 16:24PM EST
  41. US Stock Futures Down Ahead Of Wal-Mart Earnings, Economic Data

    Benzinga | Feb. 20, 2014 | 07:05AM EST
  42. CytomX Therapeutics, ImmunoGen Announce Strategic Collaboration

    Benzinga | Jan. 9, 2014 | 06:39AM EST
  43. ImmunoGen Announces Activity Reported with SAR3419 Plus Rituxan In Difficult-to-Treat Patient Population at ASH

    Benzinga | Dec. 9, 2013 | 11:31AM EST
  44. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga | Nov. 20, 2013 | 07:00AM EST
  45. ImmunoGen Announces Approval of Roche's Kadcyla in EU

    Benzinga | Nov. 20, 2013 | 05:56AM EST
  46. UPDATE: Morgan Stanley Downgrades ImmunoGen Following Phase 2 Failure of IMGN901

    Benzinga | Nov. 11, 2013 | 10:00AM EST
  47. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 11, 2013 | 08:19AM EST
  48. ImmunoGen Announces License Agreement with Novartis

    Benzinga | Nov. 11, 2013 | 06:38AM EST
  49. Mid-Afternoon Market Update: Marvell Rises on KKR Stake While Orbitz Gives Up Last Week's Gains

    Benzinga | Nov. 5, 2013 | 15:23PM EST
  50. Mid-Day Market Update: BroadSoft Drops On Q3 Results; Endo Health Shares Spike Higher

    Benzinga | Nov. 5, 2013 | 12:29PM EST
Trading Center